Disclaimer: This article is for informational purposes only and does not constitute medical advice. GLP-1 medications should only be used under physician supervision. Supplement needs vary by individual; consult a registered dietitian or physician before starting a supplementation regimen.
Part of our Sleep Optimization Blueprint guide.
GLP-1 receptor agonists — semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro), and their expanding class — have reshaped obesity medicine in ways that seemed implausible five years ago. As these medications move from clinical novelty to mainstream prescription volume, a secondary challenge has emerged: people losing significant amounts of weight rapidly on GLP-1 drugs often experience nutritional gaps that standard dietary guidance doesn’t adequately address. The natural products industry, responding to this gap, showed significant GLP-1 companion supplement activity at Expo West 2026.
What GLP-1 Drugs Do to Nutrition
The mechanism of GLP-1 agonists — suppressing appetite through hormone signaling and slowing gastric emptying — is what makes them effective for weight loss. But that same mechanism creates nutritional risk. When people eat significantly less, they consume fewer micronutrients. When stomach emptying slows, absorption of some nutrients is altered. And when weight loss is rapid (5-15% of body weight over months), lean muscle mass is at risk alongside fat mass.
Research published in SupplySide West proceedings and covered at Natural Products Expo West 2026 identified the most common nutritional concerns in GLP-1 users:
- Protein inadequacy: Users eating significantly less often don’t consume enough protein to preserve muscle mass during weight loss. The result can be a disproportionate loss of lean tissue — metabolically costly and difficult to reverse.
- B12 deficiency: Reduced gastric acid production (common in GLP-1 users) impairs B12 absorption. B12 deficiency presents insidiously — fatigue, neurological symptoms, and anemia that can take months to manifest.
- Iron: Reduced dietary intake combined with impaired absorption creates iron deficiency risk, particularly in premenopausal women already at baseline risk.
- Calcium and vitamin D: Critical for bone health, and frequently under-consumed when total food intake drops.
- Zinc and magnesium: Commonly insufficient in weight-loss diets; GLP-1 users face additional risk.
Protein: The Priority
The most important nutritional intervention for GLP-1 users is adequate protein. Research on weight loss consistently shows that higher protein intake (1.2-1.6 grams per kilogram of body weight) preserves lean mass during caloric deficit more effectively than lower intake. For GLP-1 users who may have significant appetite suppression, reaching protein targets through whole food alone can be genuinely difficult.
Protein supplementation — whey protein, plant-based protein blends, or collagen peptides — provides a practical solution. Whey in particular has the highest leucine content of common protein sources, which is the key amino acid for muscle protein synthesis signaling. For GLP-1 users who are also doing resistance training (which is strongly recommended to preserve muscle during drug-induced weight loss), protein adequacy is non-negotiable.
What Expo West 2026 Showed the Industry Is Doing
Natural Products Expo West 2026 saw a surge in products explicitly marketed to GLP-1 users — termed “GLP-1 companion” or “GLP-1 support” supplements in industry terminology. These generally combine:
- High-protein bases (whey or plant protein)
- Comprehensive micronutrient coverage (B12, D3, K2, iron, zinc, magnesium)
- Digestive enzymes (to support nutrient absorption given altered gastric motility)
- Fiber (GLP-1 users often experience constipation; additional fiber helps)
The quality and evidence base behind individual products varies enormously. Expo West products range from well-formulated evidence-backed formulas to marketing-forward products with minimal clinical foundation. Evaluating a GLP-1 companion supplement requires looking at ingredient forms (methylcobalamin vs cyanocobalamin for B12, vitamin D3 vs D2), dosages (whether they’re therapeutic or token), and third-party testing certification.
What You Should Actually Do
The most evidence-based approach for GLP-1 users concerned about nutrition is to work with a registered dietitian who can assess your specific intake and identify deficiencies through blood work, rather than self-prescribing a general supplement stack. That said, the baseline recommendations that most practitioners converge on for GLP-1 users include: meeting protein targets daily, taking a high-quality B12 supplement, ensuring vitamin D and calcium adequacy, and monitoring iron levels quarterly.
Conclusion
GLP-1 drugs are genuinely effective and their mainstream adoption is changing the landscape of obesity medicine. The nutritional management component — ensuring that weight lost is primarily fat rather than muscle, and that micronutrient stores are maintained — is the unsexy but critical complement to the medication itself. The supplement industry is responding with a growing category of companion products; the key is choosing them based on evidence rather than marketing.
Sources:
Natural Products Expo West. (2026). GLP-1 Companion Supplement Trends. expowest.com.
SupplySide West. (2025). Nutritional Management for GLP-1 Drug Users. supplysidewest.com.
Wilding, J.P.H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine.